Predictors of visual recovery in patients with macular edema secondary to central retinal vein occlusion after treatment with Conbercept

Abstract Background The use of Spectral domain optical coherence tomography (SD-OCT) to evaluate the predictors of visual acuity-recovery in patients treated with conbercept for macular edema (ME) secondary to central retinal vein occlusion (CRVO) has rarely been seen. We collected 26 CRVO-ME patien...

Full description

Bibliographic Details
Main Authors: Qi Zhang, Yinfen Hou, Xiao Cao, Rongrong Zhang, Yinping Liu, Chenghua Wei, Changfan Wu, Lixin Mei, Pengfei Zhang
Format: Article
Language:English
Published: BMC 2021-11-01
Series:BMC Ophthalmology
Subjects:
Online Access:https://doi.org/10.1186/s12886-021-02174-0
_version_ 1818752649552461824
author Qi Zhang
Yinfen Hou
Xiao Cao
Rongrong Zhang
Yinping Liu
Chenghua Wei
Changfan Wu
Lixin Mei
Pengfei Zhang
author_facet Qi Zhang
Yinfen Hou
Xiao Cao
Rongrong Zhang
Yinping Liu
Chenghua Wei
Changfan Wu
Lixin Mei
Pengfei Zhang
author_sort Qi Zhang
collection DOAJ
description Abstract Background The use of Spectral domain optical coherence tomography (SD-OCT) to evaluate the predictors of visual acuity-recovery in patients treated with conbercept for macular edema (ME) secondary to central retinal vein occlusion (CRVO) has rarely been seen. We collected 26 CRVO-ME patients with different OCT measures at 6 months follow-up to identify the factors that are most strongly correlated with the best-corrected visual acuity (BCVA) post-treatment in CRVO-ME patients treated with conbercept. Purpose To evaluate the effectiveness of intravitreal conbercept injections for the treatment of CRVO-ME and to determine the major predictors of best-corrected visual acuity (BCVA) post-treatment. Methods A retrospective study methodology was used. Twenty-six eyes from 26 patients with CRVO-ME were enrolled in the study. After an initial intravitreal injection of conbercept (0.5 mg/0.05 ml), monthly injections for up to 6 months were given following a 1 + PRN (pro re nata) regimen. Data collected at monthly intervals included measurements of the logMAR BCVA, central subfield thickness (CST), macular volume (MV), photoreceptor layer thickness (PLT), outer nuclear layer thickness (ONLT), and the disrupted ellipsoid zone (DEZ). The correlation between BCVA, before and after injections, and each of CST, MV, PLT, ONLT, DEZ was analyzed. Results The logMAR BCVA in months 3 and 6 post-injection was significantly improved relative to the baseline. In this same period the CST, MV, PLT, ONLT and DEZ were also significantly improved relative to the baseline. There was a negative correlation between PLT and logMAR BCVA at months 3 and 6 after treatment (r = − 0.549, P < 0.001; r = − 0.087, P < 0.001). Conclusion Intravitreal injection of conbercept is an effective treatment for CRVO-ME. With 6 months of follow-up, logMAR BCVA and CST, MV, PLT, ONLT, DEZ improved. PLT was negatively correlated with the visual function in CRVO-ME patients after conbercept treatment, which may be a predictor of vision recovery in patients with CRVO-ME.
first_indexed 2024-12-18T04:54:49Z
format Article
id doaj.art-b805cbff053144d38333f10fb51a1f40
institution Directory Open Access Journal
issn 1471-2415
language English
last_indexed 2024-12-18T04:54:49Z
publishDate 2021-11-01
publisher BMC
record_format Article
series BMC Ophthalmology
spelling doaj.art-b805cbff053144d38333f10fb51a1f402022-12-21T21:20:20ZengBMCBMC Ophthalmology1471-24152021-11-012111710.1186/s12886-021-02174-0Predictors of visual recovery in patients with macular edema secondary to central retinal vein occlusion after treatment with ConberceptQi Zhang0Yinfen Hou1Xiao Cao2Rongrong Zhang3Yinping Liu4Chenghua Wei5Changfan Wu6Lixin Mei7Pengfei Zhang8Department of Ophthalmology, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College)Department of Ophthalmology, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College)Department of Ophthalmology, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College)Department of Ophthalmology, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College)Department of Ophthalmology, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College)Department of Ophthalmology, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College)Department of Ophthalmology, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College)Department of Ophthalmology, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College)Department of Ophthalmology, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College)Abstract Background The use of Spectral domain optical coherence tomography (SD-OCT) to evaluate the predictors of visual acuity-recovery in patients treated with conbercept for macular edema (ME) secondary to central retinal vein occlusion (CRVO) has rarely been seen. We collected 26 CRVO-ME patients with different OCT measures at 6 months follow-up to identify the factors that are most strongly correlated with the best-corrected visual acuity (BCVA) post-treatment in CRVO-ME patients treated with conbercept. Purpose To evaluate the effectiveness of intravitreal conbercept injections for the treatment of CRVO-ME and to determine the major predictors of best-corrected visual acuity (BCVA) post-treatment. Methods A retrospective study methodology was used. Twenty-six eyes from 26 patients with CRVO-ME were enrolled in the study. After an initial intravitreal injection of conbercept (0.5 mg/0.05 ml), monthly injections for up to 6 months were given following a 1 + PRN (pro re nata) regimen. Data collected at monthly intervals included measurements of the logMAR BCVA, central subfield thickness (CST), macular volume (MV), photoreceptor layer thickness (PLT), outer nuclear layer thickness (ONLT), and the disrupted ellipsoid zone (DEZ). The correlation between BCVA, before and after injections, and each of CST, MV, PLT, ONLT, DEZ was analyzed. Results The logMAR BCVA in months 3 and 6 post-injection was significantly improved relative to the baseline. In this same period the CST, MV, PLT, ONLT and DEZ were also significantly improved relative to the baseline. There was a negative correlation between PLT and logMAR BCVA at months 3 and 6 after treatment (r = − 0.549, P < 0.001; r = − 0.087, P < 0.001). Conclusion Intravitreal injection of conbercept is an effective treatment for CRVO-ME. With 6 months of follow-up, logMAR BCVA and CST, MV, PLT, ONLT, DEZ improved. PLT was negatively correlated with the visual function in CRVO-ME patients after conbercept treatment, which may be a predictor of vision recovery in patients with CRVO-ME.https://doi.org/10.1186/s12886-021-02174-0CRVO-MEConberceptBest corrected visual acuity, predictive factor
spellingShingle Qi Zhang
Yinfen Hou
Xiao Cao
Rongrong Zhang
Yinping Liu
Chenghua Wei
Changfan Wu
Lixin Mei
Pengfei Zhang
Predictors of visual recovery in patients with macular edema secondary to central retinal vein occlusion after treatment with Conbercept
BMC Ophthalmology
CRVO-ME
Conbercept
Best corrected visual acuity, predictive factor
title Predictors of visual recovery in patients with macular edema secondary to central retinal vein occlusion after treatment with Conbercept
title_full Predictors of visual recovery in patients with macular edema secondary to central retinal vein occlusion after treatment with Conbercept
title_fullStr Predictors of visual recovery in patients with macular edema secondary to central retinal vein occlusion after treatment with Conbercept
title_full_unstemmed Predictors of visual recovery in patients with macular edema secondary to central retinal vein occlusion after treatment with Conbercept
title_short Predictors of visual recovery in patients with macular edema secondary to central retinal vein occlusion after treatment with Conbercept
title_sort predictors of visual recovery in patients with macular edema secondary to central retinal vein occlusion after treatment with conbercept
topic CRVO-ME
Conbercept
Best corrected visual acuity, predictive factor
url https://doi.org/10.1186/s12886-021-02174-0
work_keys_str_mv AT qizhang predictorsofvisualrecoveryinpatientswithmacularedemasecondarytocentralretinalveinocclusionaftertreatmentwithconbercept
AT yinfenhou predictorsofvisualrecoveryinpatientswithmacularedemasecondarytocentralretinalveinocclusionaftertreatmentwithconbercept
AT xiaocao predictorsofvisualrecoveryinpatientswithmacularedemasecondarytocentralretinalveinocclusionaftertreatmentwithconbercept
AT rongrongzhang predictorsofvisualrecoveryinpatientswithmacularedemasecondarytocentralretinalveinocclusionaftertreatmentwithconbercept
AT yinpingliu predictorsofvisualrecoveryinpatientswithmacularedemasecondarytocentralretinalveinocclusionaftertreatmentwithconbercept
AT chenghuawei predictorsofvisualrecoveryinpatientswithmacularedemasecondarytocentralretinalveinocclusionaftertreatmentwithconbercept
AT changfanwu predictorsofvisualrecoveryinpatientswithmacularedemasecondarytocentralretinalveinocclusionaftertreatmentwithconbercept
AT lixinmei predictorsofvisualrecoveryinpatientswithmacularedemasecondarytocentralretinalveinocclusionaftertreatmentwithconbercept
AT pengfeizhang predictorsofvisualrecoveryinpatientswithmacularedemasecondarytocentralretinalveinocclusionaftertreatmentwithconbercept